Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 22 pseudogene 13 is a processed pseudogene related to the RBM22 gene, which encodes an RNA binding protein involved in pre-mRNA splicing and cell division. Pseudogenes like RBM22P13 do not encode functional proteins but may act as regulatory elements, such as serving as decoys for miRNAs or RNA binding proteins, or influencing gene expression post-transcriptionally. However, there is no specific evidence for any functional or clinical role of RBM22P13, nor is it considered a therapeutic target, receptor, enzyme, or protein of clinical interest. This target is likely incorrect for purposes such as drug discovery, clinical targeting, or functional protein studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 22 pseudogene 13 (RBM22P13).